Arboviral vaccines for use in pregnant travelers

S L Hills; J M Wong; J E Staples

doi:10.1016/j.tmaid.2023.102624

Arboviral vaccines for use in pregnant travelers

Travel Med Infect Dis. 2023 Sep-Oct:55:102624. doi: 10.1016/j.tmaid.2023.102624. Epub 2023 Jul 28.

Authors

S L Hills¹, J M Wong², J E Staples³

Affiliations

¹ Arboviral Diseases Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, USA. Electronic address: shills@cdc.gov.
² Dengue Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, San Juan, PR, USA.
³ Arboviral Diseases Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, CO, USA.

PMID: 37517630
DOI: 10.1016/j.tmaid.2023.102624

Abstract

Pregnant women traveling abroad can be exposed to a variety of arboviruses, primarily spread by mosquitoes or ticks. Some arboviral infections can be of particular concern for pregnant women or their fetuses. Vaccination is one preventive measure that can reduce the risk for infection. Several arboviral vaccines have been licensed for many years and can be used to prevent infection in travelers, namely Japanese encephalitis, yellow fever, and tick-borne encephalitis vaccines. Recommendations on use of these vaccines in pregnancy vary. Other arboviral vaccines have been licensed but are not indicated for use in pregnant travelers (e.g., dengue vaccines) or are in development (e.g., chikungunya, Zika vaccines). This review describes arboviral vaccines for travelers, focusing on women who are pregnant and those planning travel during pregnancy.

Keywords: Dengue; Fetus; Japanese encephalitis; Pregnancy; Tick-borne encephalitis; Yellow fever.